An Observational Cohort Study of the 2-Month Use of Regional Citrate Anticoagulation in Maintenance Hemodialysis Patients with Cerebral Hemorrhage

Xiao Bi; Qi Zhang; Feng Zhuang; Wei Lu; Yingdeng Wang; Feng Ding

doi:10.12659/MSM.930513

16 April 2021 : Clinical Research

An Observational Cohort Study of the 2-Month Use of Regional Citrate Anticoagulation in Maintenance Hemodialysis Patients with Cerebral Hemorrhage

Xiao Bi^1ABCDEF, Qi Zhang^1ABE, Feng Zhuang^1B, Wei Lu^1B, Yingdeng Wang^1AE, Feng Ding^1ADE*

DOI: 10.12659/MSM.930513

Med Sci Monit 2021; 27:e930513

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 3 The trend of total magnesium, fibroblast growth factor (FGF)-23 in patients treated with 4 weeks of regional citrate anticoagulation (RCA) treatment and subsequent 4 weeks of heparin anticoagulation: (A) total magnesium; (B) FGF-23; (C) PINP.

Back to the Article

An Observational Cohort Study of the 2-Month Use of Regional Citrate Anticoagulation in Maintenance Hemodialysis Patients with Cerebral Hemorrhage

Your Privacy